Showing results (1-10 of 30) with videos related to
Sort By:
Pageof 3
Computational and Mathematical Methods in Medicine|September 2, 2021
ACE2 Promotes the Synthesis of Pulmonary Surfactant to Improve AT II Cell Injury via SIRT1/eNOS PathwayHailing Xu, Jianguang XiaoJournal of the College of Physicians and Surgeons--Pakistan : JCPSP|March 3, 2019
Inhaled Glucocorticoid with or without Tiotropium Bromide for Asthma-Chronic Obstructive Pulmonary Disease Overlap SyndromeHailing Xu, Xiaoxia LuBehavioral Sciences (Basel, Switzerland)|July 25, 2022
Research on the Mechanism of Influence of Game Competition Mode on Online Learning PerformanceHailing Xu, Shilun Ge, Feng YuanIEEE Transactions on Bio-Medical Engineering|January 12, 2026
Multimodal Spiking Neural Network With Generalized Distributive Law for Biosignal and Sensory FusionZenan Huang, Bingrui Guo, Hailing Xu, et al.Cancer Management and Research|July 26, 2023
CD73 Dysregulates Monocyte Anti-Tumor Activity in Multiple MyelomaLin Zhou, XiaoLan Liu, Tao Guan, et al.Biomed Research International|October 8, 2020
USP46 Inhibits Cell Proliferation in Lung Cancer through PHLPP1/AKT PathwayWei Wang, Meng Chen, Hailing Xu, et al.Journal of Agricultural and Food Chemistry|July 25, 2018
Clostridium butyricum Attenuates Chronic Unpredictable Mild Stress-Induced Depressive-Like Behavior in Mice via the Gut-Brain AxisJing Sun, Fangyan Wang, Xuezhen Hu, et al.Lung Cancer (Amsterdam, Netherlands)|August 21, 2023
Efficacy and safety of re-challenging 160 mg furmonertinib for advanced NSCLC after resistance to third-generation EGFR-TKIs targeted agents: A real-world studyRongbin Qi, Xinyu Fu, Yingying Yu, et al.Frontiers in Oncology|August 18, 2023
Case Report: Keratoacanthoma and type I diabetes secondary to treatment with PM8001, a bifunctional fusion protein targeting TGF-β and PD-L1Rongbin Qi, Hailing Xu, Xinyu Fu, et al.Therapeutic Advances in Medical Oncology|November 6, 2024
Early stereotactic body radiation therapy improves progression-free survival of first-generation EGFR tyrosine kinase inhibitors in EGFR-mutated lung cancer: an observational cohort studyHailing Xu, Rongbin Qi, Chao Zhou, et al.Pageof 3